174 related articles for article (PubMed ID: 31413847)
1. Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms.
Takashio S; Takahama H; Nishikimi T; Hayashi T; Nagai-Okatani C; Matsuo A; Nakagawa Y; Amano M; Hamatani Y; Okada A; Amaki M; Hasegawa T; Kanzaki H; Yasuda S; Kangawa K; Anzai T; Minamino N; Izumi C
Open Heart; 2019; 6(2):e001072. PubMed ID: 31413847
[TBL] [Abstract][Full Text] [Related]
2. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
3. Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP.
Reginauld SH; Cannone V; Iyer S; Scott C; Bailey K; Schaefer J; Chen Y; Sangaralingham SJ; Burnett JC
JACC Heart Fail; 2019 Oct; 7(10):891-898. PubMed ID: 31521687
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
5. Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study.
Schneider MP; Schmid M; Nadal J; Krane V; Saritas T; Busch M; Schultheiss UT; Meiselbach H; Friedrich N; Nauck M; Floege J; Kronenberg F; Wanner C; Eckardt KU;
Kidney Med; 2023 Nov; 5(11):100725. PubMed ID: 37915964
[TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
[TBL] [Abstract][Full Text] [Related]
7. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
[TBL] [Abstract][Full Text] [Related]
8. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
[TBL] [Abstract][Full Text] [Related]
9. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
[TBL] [Abstract][Full Text] [Related]
10. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
Loke I; Squire IB; Davies JE; Ng LL
Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
[TBL] [Abstract][Full Text] [Related]
11. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
[TBL] [Abstract][Full Text] [Related]
12. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the N-terminal pro-brain natriuretic peptide and B-type natriuretic peptide ratio in the acute phase of acute heart failure.
Sawatani T; Shirakabe A; Okazaki H; Matsushita M; Shibata Y; Shigihara S; Otsuka Y; Kiuchi K; Kobayashi N; Hata N; Shimizu W; Asai K
Eur Heart J Acute Cardiovasc Care; 2021 Dec; 10(9):1016-1026. PubMed ID: 34432003
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
[TBL] [Abstract][Full Text] [Related]
19. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
20. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.
Zoccali C; Mallamaci F; Benedetto FA; Tripepi G; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Cottini E; Malatino LS
J Am Soc Nephrol; 2001 Jul; 12(7):1508-1515. PubMed ID: 11423580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
